Keyphrases
Acute Lymphoblastic Leukemia
100%
Etoposide
100%
Secondary Acute Myeloid Leukemia (sAML)
100%
VP16
40%
Epipodophyllotoxin
40%
Event-free Survival
20%
Childhood Acute Lymphoblastic Leukemia
20%
Cytarabine
20%
Alkylating Agents
20%
Dallas-Fort Worth
20%
6-mercaptopurine (6-MP)
20%
Two-dose
20%
L-asparaginase
20%
Divided Dose
20%
Oral Methotrexate
20%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
20%
Remission
20%
Treatment Duration
20%
Irradiation
20%
Drug Induction
20%
Ara-C
20%
L-Asp
20%
Serious Complications
20%
Inappropriate Use
20%
Mercaptopurine
20%
Intravesical Chemotherapy
20%
Bone Marrow Relapse
20%
Continuation Phase
20%
Consolidation Phase
20%
Medicine and Dentistry
Etoposide
100%
Acute Lymphoblastic Leukemia
100%
Secondary Acute Myeloid Leukemia
100%
Leukemia in Children
100%
Cytarabine
33%
Epipodophyllotoxin
33%
Event Free Survival
16%
Alkylating Antineoplastic Agent
16%
Asparaginase
16%
Methotrexate
16%
Mercaptopurine
16%
Intrathecal Drug Administration
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Etoposide
100%
Secondary Acute Myeloid Leukemia
100%
Cytarabine
33%
Epipodophyllotoxin
33%
Alkylating Agent
16%
Chemotherapy
16%
Remission
16%
Asparaginase
16%
Intrathecal
16%
Mercaptopurine
16%
Methotrexate
16%
Event Free Survival
16%